Regeneron

Regeneron/Teva pain drug fasinumab on target in phase 3

https://pharmaphorum.com/news/regeneron-teva-pain-drug-fasinumab-target-phase-3/

Regeneron forges CAR-T R&D partnership with bluebird bio

https://pharmaphorum.com/news/regeneron-forges-car-t-rd-partnership-with-bluebird-bio/

Amgen’s Repatha gets EU cardio risk reduction label

https://pharmaphorum.com/news/amgens-repatha-gets-eu-cardio-risk-reduction-label/

Regeneron and Alnylam seek RNAi therapies for NASH

https://pharmaphorum.com/news/regeneron-alnylam-seek-rnai-therapies-nash/

Double blow to Amgen with Sanofi’s Praluent data and price cut

https://pharmaphorum.com/news/sanofi-deals-double-blow-amgen-praluent-data-price-cut/

Regeneron: Biobank project offers hope for Alzheimer’s R&D

https://pharmaphorum.com/news/genome-sequencing-offers-hope-alzheimers-rd/

Regeneron/Bayer axe eye combination drug

https://pharmaphorum.com/news/regeneronbayer-axe-eye-combination-drug/

Regeneron ends development of RSV antibody

https://pharmaphorum.com/news/regeneron-ends-development-of-rsv-antibody/

Sanofi’s RA drug Kevzara approved in Europe

https://pharmaphorum.com/news/sanofis-kevzara-approved-europe/

1 2 3

Close in 10 seconds

Pharmaphorum.com

Search